Metagenomi Inc

Research Metagenomi Inc (MGX) on Bullrun: market cap USD 45.18M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerMGX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 45.18M
• Financial periodFY2025
• RevenueUSD 25.21M
• Revenue growth-51.8%
• Net income-USD 87.87M
• Free cash flow-USD 89.47M

Valuation Snapshot

latest market cap is USD 45.18M.

About Metagenomi Inc

Metagenomi Therapeutics, Inc. an in vivo genome editing company, develops curative genetic medicines in the United States. The company's lead development program, MGX-001, is designed to provide curative, life-long protection from bleeding events and joint damage in adults and children with hemophilia. It has a collaboration agreement with Ionis Pharmaceuticals, Inc.

Frequently asked questions

What is Metagenomi Inc's market cap?

Metagenomi Inc's market capitalization is USD 45.18M.

What does Metagenomi Inc do?

Metagenomi Therapeutics, Inc. an in vivo genome editing company, develops curative genetic medicines in the United States.